A recent study published in Pediatrics explored how the Adderall shortage, starting in October 2022, affected stimulant prescriptions for children with ADHD. Researchers, including the University of Michigan’s Sijia He and Kao-Ping Chua, noted shifts in medication patterns and emphasized the need for further research and policy adjustments to ensure continued access to effective treatments. Are you curious about how this shortage might be impacting ADHD management? Read the full article to learn more about the surprising shifts in treatment and what it could mean for children’s health.
